Assessing bleeding risk in acute coronary syndromes

Rev Esp Cardiol (Engl Ed). 2012 Jan;65(1):4-6. doi: 10.1016/j.recesp.2011.08.005. Epub 2011 Nov 5.
[Article in English, Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Acute Coronary Syndrome / complications*
  • Acute Coronary Syndrome / epidemiology
  • Acute Coronary Syndrome / mortality
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use
  • Forecasting
  • Hemorrhage / epidemiology*
  • Hemorrhage / etiology*
  • Hemorrhage / prevention & control
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use
  • Risk Assessment

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors